Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in DSGN — Design Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$442,970
+$223,318 QoQ
Shares Held
30,613
+48.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 136 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. DSGN ranks #186 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in DSGN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $442,970 30,613
2026-03-31 $219,652 20,644
2025-12-31 $145,774 15,541
2025-06-30 $94,676 28,094
2025-03-31 $108,577 28,129
2024-12-31 $173,339 28,094
2024-09-30 $151,145 28,094
2024-06-30 $94,114 28,094
2024-03-31 $113,218 28,094
2023-12-31 $74,449 28,094
2023-09-30 $1,201 509
2023-06-30 $100,176 15,901
2023-03-31 $143,418 24,856
2022-12-31 $183,048 17,841
2022-09-30 $230,050 13,759
2022-06-30 $224,280 16,020
2022-03-31 $238,858 14,790
2021-12-31 $364,355 17,018
2021-09-30 $117,740 8,015
2021-06-30 $159,120 8,000